Wikipedia -WSS

Wikipedia

author：leisure time 2025-10-01 21:36:47 - browse：3

Eli Lilly headquarters — Kristoffer Tripplaar/AP

SAN DIEGO – An experimental pill from Eli Lilly led to 14.7% weight loss on the highest dose in a 36-week trial, heating up the growing competition among drugmakers to develop an effective oral obesity therapy.

The mid-stage results for orforglipron match the estimates of 14-15% weight loss that Lilly gave in an investor call late last year. The full results, published Friday in the New England Journal of Medicine, were presented here to a packed conference room at the American Diabetes Association conference.

By the end of trial, the authors said, participants’ weight loss had not plateaued, suggesting potential for even greater weight loss over a longer treatment period.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Dewpoint Therapeutics lays off staff after losing partnerships

WSS

Francis Collins on trust in science and how Covid communications failed

Biotech venture capitalists face new demands from investors

Listen: Who gets the credit for GLP

Paxlovid should be available without a positive Covid test

Copay coupons to count toward deductibles, after Biden court move

Think you might have Covid

hotspot

Wikipedia

hotspot

Peter Hotez and the public health issue of online harassment

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

Medical records are filled with copy

My yearlong odyssey to get my son’s ADHD medication covered

Virginia high school admissions case could be legal follow

Sudafed saga points to U.S. issues with evaluating older drugs

Activists slam private health insurers over coverage restrictions

Elizabeth Holmes banned from government health programs

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

NIH director takes cautious approach to Biden drug pricing priority

Wikipedia

How digital therapeutics firms are pivoting after Pear's bankruptcy

Independent physicians launch a new lobbying group

Francis Collins on trust in science and how Covid communications failed

After a drawn out lobbying fight, ARPA

After a drawn out lobbying fight, ARPA

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

explore

Wikipedia

focus

focus